Lionheart Health, Inc., a California-based biotechnology company, has been selected as one of the 40 semi-finalists in the $101M XPRIZE Healthspan Competition for its innovative technology platform that utilizes precise bioelectric signaling sequences to promote regeneration and renewal.
